Skip to Content

Xylem Inc

XYL: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$753.00FgxmlCzgxtnkg

Xylem Earnings: Full-Year Outlook Raised on Improved Profitability

Narrow-moat-rated Xylem reported strong first-quarter results, increasing adjusted earnings per share by 14% from the prior-year period. We’ve raised our fair value estimate to $110 per share from $106 to reflect our slightly more optimistic near-term revenue growth and operating margin expectations as well as the time value of money.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of XYL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center